Skip to main content
Log in

NMDA component in the effects of piracetam and new nootropic peptide GVS-111 on the neocortical and hippocampal EEG in conscious rats

  • Pharmacology and Toxicology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

The effects of new nootropic dipeptide GVS-111 (N-phenylacetyl-L-prolylglycine ethyl ester) on EEG spectral characteristics were compared with those of piracetam. The EEG was recorded in the cortex and hippocampus of nonanesthetized nonrestrained rats with chronically implanted electrodes. GVS-111 and piracetam induced similar changes in EEG spectral profile in both structures increasing the α-band power and decreasing the power of the β-and δ-bands. These effects were prevented by intracerebral injection of 10−10 mol NMDA receptor antagonist (±)-3-(2-carboxypiperazine-4-il)-propyl-l-phosphonic acid. The data correlate with behavioral and neurochemical findings and suggest that NMDA receptors can be specifically involved in the mechanisms of nootropic effects of piracetam and GVS-111.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. V. V. Vorob'ev, E. R. Akhmetova, and G. I. Kovalev,Eksp. Klin. Farmacol.,6, No. 5, 11–14 (1997).

    Google Scholar 

  2. T. A. Voronina, S. V. Krapivin, and N. N. Bogdanov,Vestn. Akad. Med. Nauk SSSR, No. 2, 17–27 (1987).

    PubMed  Google Scholar 

  3. A. A. Gal'chenko and V. V. Vorob'ev,Ros. Fiziol. Zh.,84, No. 3 263–266 (1998).

    Google Scholar 

  4. T. A. Gudasheva, R. U. Ostrovskaya, S. S. Trofimov, et al.,Khim. Farm. Zh.,19, 1322–1329 (1985).

    CAS  Google Scholar 

  5. S. V. Panyushkina and A. S. Avetisova,Eksp. Klin. Farmakol.,55, No. 3, 14–17 (1992).

    CAS  Google Scholar 

  6. T. A. Gudasheva, S. S. Boyko, R. U. Ostrovskaya, et al.,Eur. J. Drug Metab. Pharmacokinet.,22, No. 3, 245–252 (1997).

    Article  PubMed  CAS  Google Scholar 

  7. T. A. Gudasheva, T. A. Voronina, R. U. Ostrovskaya, et al.,Eur. J. Med. Chem.,31, No. 2, 151–157 (1996).

    Article  CAS  Google Scholar 

  8. G. I. Kovalev, R. R. Gainetdinov, R. M. Salimov, et al.,Pharmacol. Res.,31, Suppl., 263 (1995).

    Article  Google Scholar 

  9. R. U. Ostrovskaya, T. A. Gudasheva, S. S. Trofimov,et al., in:Biological Basis of Individual Sensitivity to Psychotropic Drugs, Eds. S. B. Seredeninet al., Edinburgh (1994) pp. 80–91.

  10. R. U. Ostrovskaya, G. I. Kovalev, G. A. Romanova, et al.,J. Neurochem.,71, Suppl. 1, S54B (1998).

    Google Scholar 

  11. L. L. Pellegrino, A. S. Pellegrino, and A. J. Cushman,A Stereotaxic Atlas of the Rat Brain, New York (1979).

  12. J. Volavka, J. Simeon, S. Simeon,et al., Psychopharmacology (Berlin), 185–188 (1981).

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByullenten' Eksperimental'noi Biologii i Meditsiny, Vol. 128, No. 8, pp. 190–193, August, 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kovalev, G.I., Vorob'ev, V.V. & Akhmetova, E.R. NMDA component in the effects of piracetam and new nootropic peptide GVS-111 on the neocortical and hippocampal EEG in conscious rats. Bull Exp Biol Med 128, 822–825 (1999). https://doi.org/10.1007/BF02433825

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02433825

Key words

Navigation